Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

23.88

+0.37 (1.57%)

At close: Aug 21, 2026, 4:00 PM EDT

24.02

+0.14 (0.59%)

After-hours: Aug 21, 2026, 7:45 PM EDT

Tango Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	345.56	112.28	69.53	66.39	59.97	142.75
Short-Term Investments	668.43	230.86	188.39	270.5	306.17	342.51
Cash & Short-Term Investments	1,014	343.14	257.92	336.89	366.13	485.26
Cash Growth	460.88%	33.04%	-23.44%	-7.99%	-24.55%	154.97%
Receivables	-	-	-	-	2	2
Prepaid Expenses	17.68	10.19	8.43	8.8	6.57	4.52
Restricted Cash	-	0.43	-	0.86	0.57	0.57
Total Current Assets	1,032	353.76	266.34	346.54	375.27	492.34
Property, Plant & Equipment	39.76	42.49	47.58	53.42	57.77	6.09
Long-Term Investments	-	0.5	-	-	-	-
Other Long-Term Assets	2.45	1.94	2.57	2.61	3.43	1.73
Total Assets	1,074	398.69	316.49	402.57	436.47	500.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.81	1.18	1.6	2.79	4.45	3.23
Accrued Expenses	12.71	16.47	14.76	14.11	16.23	9.22
Current Portion of Leases	2.94	2.74	2.45	2.08	1.77	1.5
Current Income Taxes Payable	-	-	-	-	0.04	0.05
Current Unearned Revenue	-	-	17.62	25.67	31.79	26.02
Other Current Liabilities	2.83	1.29	1.74	1.29	1.27	0.67
Total Current Liabilities	20.3	21.68	38.17	45.94	55.55	40.69
Long-Term Leases	29.05	30.83	34.04	36.84	39.36	-
Long-Term Unearned Revenue	-	-	44.77	66.68	92.09	114.72
Total Liabilities	49.35	52.51	116.98	149.46	186.99	155.41

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.17	0.14	0.11	0.1	0.09	0.09
Additional Paid-In Capital	1,729	948.97	700.63	624.08	522.61	506.76
Retained Earnings	-704.01	-603.15	-501.56	-371.26	-269.51	-161.34
Comprehensive Income & Other	-0.63	0.22	0.34	0.19	-3.71	-0.77
Total Common Equity	1,025	346.18	199.52	253.11	249.48	344.75
Shareholders' Equity	1,025	346.18	199.52	253.11	249.48	344.75
Total Liabilities & Equity	1,074	398.69	316.49	402.57	436.47	500.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	31.99	33.57	36.49	38.92	41.13	1.5
Net Cash (Debt)	982	309.57	221.42	297.97	325	483.75
Net Cash Growth	573.63%	39.81%	-25.69%	-8.32%	-32.82%	165.16%
Net Cash Per Share	7.26	2.66	2.03	3.15	3.70	7.79
Filing Date Shares Outstanding	168.61	142.69	108.11	106.72	88.2	87.71
Total Common Shares Outstanding	168.38	135.94	107.73	102.2	88.18	87.6
Working Capital	1,011	332.08	228.17	300.6	319.73	451.65
Book Value Per Share	6.08	2.55	1.85	2.48	2.83	3.94
Tangible Book Value	1,025	346.18	199.52	253.11	249.48	344.75
Tangible Book Value Per Share	6.08	2.55	1.85	2.48	2.83	3.94
Machinery	13.39	13.56	13.32	12.88	11.65	6.25
Construction In Progress	0.14	-	0.15	0.04	0.01	0.74
Leasehold Improvements	3.72	3.72	2.87	2.86	2.78	0.25

SEC Filings: 10-K · 10-Q